Righini M, Nendaz M, Le Gal G, Bounameaux H, Perrier A
Division of Angiology and Haemostasis, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.
J Thromb Haemost. 2007 Sep;5(9):1869-77. doi: 10.1111/j.1538-7836.2007.02667.x. Epub 2007 Jun 26.
Age has a marked effect on the diagnostic yield of D-dimer measurement and lower limb compression ultrasonography (CUS) in patients with suspected pulmonary embolism (PE), suggesting that specific diagnostic strategies may be needed in elderly patients.
To evaluate the cost-effectiveness of including D-dimer and CUS in the workup of PE, with particular attention to patient age.
We analyzed data from two recent outcome studies that enrolled 1721 consecutive outpatients with suspected PE. Both studies used a sequential diagnostic strategy that included assessment of clinical probability, D-dimer measurement, CUS, and helical computed tomography (hCT). A decision analysis model was created for analyzing cost-effectiveness according to six classes of age. The main outcome measures were 3-month quality-adjusted expected survival and costs per patient managed.
All strategies were equally safe, with variations in the 3-month survival never exceeding 0.5% as compared to the most effective strategy. D-dimer measurement was highly cost-saving under the age of 80 years. Above 80 years, the cost-sparing effect of D-dimer was diminished, but not completely abolished. Inclusion of CUS increased the costs of diagnostic strategies irrespective of age. Results were unchanged over a wide range of the variables of interest (costs, sensitivity, and specificity of the tests).
Diagnostic strategies using D-dimer are less expensive. The cost-sparing effect of D-dimer is reduced but not abolished above 80 years, suggesting that adapting specific diagnostic strategies in elderly outpatients is not mandatory. CUS is costly, and only marginally improves the safety of diagnostic strategies for PE.
年龄对疑似肺栓塞(PE)患者D-二聚体检测及下肢加压超声检查(CUS)的诊断率有显著影响,提示老年患者可能需要特定的诊断策略。
评估在PE检查中纳入D-二聚体和CUS的成本效益,尤其关注患者年龄。
我们分析了两项近期结局研究的数据,这两项研究纳入了1721例连续的疑似PE门诊患者。两项研究均采用序贯诊断策略,包括临床可能性评估、D-二聚体检测、CUS及螺旋计算机断层扫描(hCT)。创建了一个决策分析模型,根据六个年龄类别分析成本效益。主要结局指标为3个月质量调整预期生存率及每位接受治疗患者的成本。
所有策略同样安全,与最有效策略相比,3个月生存率的差异从未超过0.5%。80岁以下患者,D-二聚体检测极具成本节约效益。80岁以上,D-二聚体的成本节约效果减弱,但未完全消失。无论年龄如何,纳入CUS都会增加诊断策略的成本。在广泛的相关变量(成本、检测的敏感性和特异性)范围内,结果不变。
使用D-二聚体的诊断策略成本较低。80岁以上,D-二聚体的成本节约效果降低但未消失,这表明在老年门诊患者中调整特定诊断策略并非必需。CUS成本高昂,且仅能略微提高PE诊断策略的安全性。